CRP and PCT can be used to evaluate disease severity and predict outcomes in patients with COVID-19 (Liu et al., 2020; Pan et al., 2020; Zhang et al., 2020, 2021; Zhou Y.Z. et al., 2021). The gene discussed is CALCA; the disease is COVID-19.